BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV 20.05% 41.93% 51.59% 42.58% 20.67% 9.55% 2.60% 0.91% 15.79% 04/07/2010
BIB Market Price 20.06% 42.12% 51.73% 42.51% 20.92% 9.51% 2.55% 0.91% 15.79% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 11/14/2025
  • NAV
    $75.39
  • NAV Change
    $+0.91 up caret
  • Market Price
    $75.48
  • Market Price Change
    $+1.01 up caret
  • Trading Volume (M)
    17,513
  • 30-Day Median Bid Ask Spread
    0.29%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 11/14/2025
  • NAV
    $75.39
  • NAV Change
    $+0.91 up caret
  • Market Price
    $75.48
  • Market Price Change
    $+1.01 up caret
  • Trading Volume (M)
    17,513
  • 30-Day Median Bid Ask Spread
    0.29%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 9/30/2025

Holdings

as of 11/14/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
5.23% AMGN AMGEN INC -- $4,019,328.64 11,936 2023607
4.99% VRTX VERTEX PHARMACEUTICALS INC -- $3,839,925.60 8,784 2931034
4.94% GILD GILEAD SCIENCES INC -- $3,800,983.06 30,403 2369174
3.87% REGN REGENERON PHARMACEUTICALS -- $2,973,728.00 4,288 2730190
3.15% ALNY ALNYLAM PHARMACEUTICALS INC -- $2,423,667.36 5,396 B00FWN1
2.49% AZN ASTRAZENECA PLC-SPONS ADR -- $1,915,026.30 21,493 2989044
2.20% INSM INSMED INC -- $1,695,312.28 8,774 2614487
1.50% ARGX ARGENX SE - ADR -- $1,152,226.62 1,269 BDVLM39
1.33% BIIB BIOGEN INC -- $1,019,709.30 6,086 2455965
1.14% UTHR UNITED THERAPEUTICS CORP -- $875,432.80 1,877 2430412
1.10% INCY INCYTE CORP -- $844,135.75 8,105 2471950
1.00% ILMN ILLUMINA INC -- $769,753.93 6,379 2613990
0.91% RPRX ROYALTY PHARMA PLC- CL A -- $702,608.72 17,942 BMVP7Y0
0.90% MEDP MEDPACE HOLDINGS INC -- $688,635.03 1,167 BDCBC61
0.78% NBIX NEUROCRINE BIOSCIENCES INC -- $596,098.90 4,115 2623911
0.76% SNY SANOFI-ADR -- $580,683.18 11,137 2964557
0.75% ROIV ROIVANT SCIENCES LTD -- $575,059.18 28,342 BMW4NZ9
0.72% SMMT SUMMIT THERAPEUTICS INC -- $555,882.93 30,831 BMTVQS7
0.68% BBIO BRIDGEBIO PHARMA INC -- $526,605.48 7,932 BK1KWG8
0.68% RVMD REVOLUTION MEDICINES INC -- $525,604.50 7,758 BL71K91
0.67% VTRS VIATRIS INC -- $518,697.92 48,386 BMWS3X9
0.67% ASND ASCENDIS PHARMA A/S - ADR -- $515,905.60 2,524 BV9G6B8
0.66% ONC BEONE MEDICINES LTD-ADR -- $510,318.90 1,395 BYYWPW6
0.64% MDGL MADRIGAL PHARMACEUTICALS INC -- $488,990.04 924 BD59BS7
0.64% GH GUARDANT HEALTH INC -- $488,553.49 5,177 BFXC911
0.62% TEM TEMPUS AI INC -- $479,428.48 7,001 BSLSJJ0
0.62% IONS IONIS PHARMACEUTICALS INC -- $473,160.15 6,613 BDJ0LS6
0.61% EXEL EXELIXIS INC -- $465,313.80 11,172 2576941
0.57% BMRN BIOMARIN PHARMACEUTICAL INC -- $436,143.37 7,969 2437071
0.56% BNTX BIONTECH SE-ADR -- $430,297.66 4,174 BK6H543
0.52% MRNA MODERNA INC -- $399,985.96 16,148 BGSXTS3
0.49% RNA AVIDITY BIOSCIENCES INC -- $378,001.20 5,339 BMWHPY1
0.46% JAZZ JAZZ PHARMACEUTICALS PLC -- $354,932.12 2,516 B4Q5ZN4
0.44% HALO HALOZYME THERAPEUTICS INC -- $339,925.62 4,854 2975098
0.43% CYTK CYTOKINETICS INC -- $330,007.48 4,967 BBBSBJ5
0.39% MRUS MERUS NV -- $301,091.10 3,138 BZBY005
0.38% AXSM AXSOME THERAPEUTICS INC -- $289,437.68 2,072 BYZR4X4
0.36% RYTM RHYTHM PHARMACEUTICALS INC -- $274,172.78 2,758 BF2YWG4
0.35% NUVL NUVALENT INC-A -- $267,015.50 2,767 BMVBZD3
0.34% PCVX VAXCYTE INC -- $262,341.72 5,388 BKPVGH6
0.32% PTCT PTC THERAPEUTICS INC -- $248,414.70 3,299 B17VCN9
0.32% KRYS KRYSTAL BIOTECH INC -- $247,392.00 1,200 BD6JX35
0.31% ARWR ARROWHEAD PHARMACEUTICALS IN -- $236,791.14 5,739 BYQBFJ8
0.28% PTGX PROTAGONIST THERAPEUTICS INC -- $218,378.41 2,581 BDCBCD8
0.27% ACLX ARCELLX INC -- $207,043.98 2,301 BPCJ1Q2
0.26% ALKS ALKERMES PLC -- $198,982.08 6,852 B3P6D26
0.26% CRSP CRISPR THERAPEUTICS AG -- $198,195.69 3,773 BDHF4K6
0.25% COGT COGENT BIOSCIENCES INC -- $194,498.46 5,799 BLR6XK8
0.25% KYMR KYMERA THERAPEUTICS INC -- $192,741.92 2,968 BMPRZV5
0.23% AKRO AKERO THERAPEUTICS INC -- $180,110.00 3,320 BK7Y2V9
0.23% -- NEWAMSTERDAM PHARMA CO NV -- $179,209.55 4,673 BP8JSP4
0.22% IMVT IMMUNOVANT INC -- $171,711.42 7,233 BJRFSB7
0.22% ACAD ACADIA PHARMACEUTICALS INC -- $168,188.04 7,002 2713317
0.22% CRNX CRINETICS PHARMACEUTICALS IN -- $166,711.69 3,907 BDD19F8
0.21% LGND LIGAND PHARMACEUTICALS -- $163,500.04 814 2501578
0.21% PRAX PRAXIS PRECISION MEDICINES I -- $163,117.50 875 BQ721R4
0.21% INDV INDIVIOR PLC -- $157,907.71 5,179 BP0BQQ5
0.20% ADMA ADMA BIOLOGICS INC -- $154,106.24 9,904 B9NSBM2
0.20% AMRX AMNEAL PHARMACEUTICALS INC -- $151,727.40 13,035 BFNF1D6
0.19% SRRK SCHOLAR ROCK HOLDING CORP -- $149,303.31 3,991 BFZQ0L8
0.19% MIRM MIRUM PHARMACEUTICALS INC -- $148,952.40 2,085 BJDX8Y8
0.17% RARE ULTRAGENYX PHARMACEUTICAL IN -- $132,353.08 4,001 BJ62Z18
0.17% XENE XENON PHARMACEUTICALS INC -- $130,391.24 3,199 BRJ3GY4
0.17% IRON DISC MEDICINE INC -- $129,887.80 1,444 BMGJZJ8
0.17% CGON CG ONCOLOGY INC -- $129,837.66 3,166 BRBCSP4
0.17% VCYT VERACYTE INC -- $128,477.75 3,265 BFTWZY0
0.17% TARS TARSUS PHARMACEUTICALS INC -- $127,682.92 1,751 BMH5RL1
0.17% TVTX TRAVERE THERAPEUTICS INC -- $127,581.00 3,698 BLFGJD5
0.16% APGE APOGEE THERAPEUTICS INC -- $125,432.50 1,915 BM9HHL5
0.16% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $124,425.00 4,977 BKX9VD3
0.16% FOLD AMICUS THERAPEUTICS INC -- $121,287.12 12,794 B19FQ48
0.16% GRAL GRAIL INC -- $119,285.74 1,498 BSLSSX7
0.15% IDYA IDEAYA BIOSCIENCES INC -- $116,861.04 3,636 BK0VHF6
0.15% MLYS MINERALYS THERAPEUTICS INC -- $112,460.05 2,753 BP9N0G0
0.14% DYN DYNE THERAPEUTICS INC -- $110,936.16 5,904 BN15WD1
0.14% CNTA CENTESSA PHARMACEUTICALS-ADR -- $109,887.80 3,980 BLB0YQ9
0.14% APLS APELLIS PHARMACEUTICALS INC -- $106,590.19 5,243 BYTQ6X1
0.14% DNLI DENALI THERAPEUTICS INC -- $105,860.80 6,070 BD2B4V0
0.14% LEGN LEGEND BIOTECH CORP-ADR -- $105,802.97 3,493 BMX9K07
0.14% AGIO AGIOS PHARMACEUTICALS INC -- $105,283.80 2,412 BCBVTX1
0.14% SUPN SUPERNUS PHARMACEUTICALS INC -- $104,805.00 2,329 B72ZBG4
0.13% EWTX EDGEWISE THERAPEUTICS INC -- $99,463.00 4,372 BKY5JZ8
0.12% AVDL AVADEL PHARMACEUTICALS -- $94,923.24 4,029 BDGMC59
0.12% BEAM BEAM THERAPEUTICS INC -- $91,224.00 4,200 BK6L288
0.12% GPCR STRUCTURE THERAPEUTICS INC -- $91,092.68 2,474 BQS9486
0.12% ADPT ADAPTIVE BIOTECHNOLOGIES -- $89,097.90 6,319 BJ5FZ74
0.11% AUPH AURINIA PHARMACEUTICALS INC -- $83,872.40 5,464 BFWLC09
0.11% VCEL VERICEL CORP -- $83,426.98 2,093 BSBMN89
0.11% TERN TERNS PHARMACEUTICALS INC -- $81,892.80 3,630 BMDJ0C9
0.11% IBRX IMMUNITYBIO INC -- $81,600.48 39,231 BNSP0B8
0.11% OCUL OCULAR THERAPEUTIX INC -- $81,597.30 7,221 BNZB1X8
0.11% HRMY HARMONY BIOSCIENCES HOLDINGS -- $81,195.58 2,386 BKSGZN7
0.10% SRPT SAREPTA THERAPEUTICS INC -- $76,312.17 4,057 B8DPDT7
0.10% ANIP ANI PHARMACEUTICALS INC -- $75,618.00 900 BCDWBX6
0.10% TXG 10X GENOMICS INC-CLASS A -- $75,477.50 4,750 BKS3RS7
0.10% VERA VERA THERAPEUTICS INC -- $75,070.80 2,648 BL55460
0.10% RXRX RECURSION PHARMACEUTICALS-A -- $73,422.90 17,735 BM9FJ13
0.09% JANX JANUX THERAPEUTICS INC -- $73,024.32 2,494 BMFX8Y7
0.09% KNSA KINIKSA PHARMACEUTICALS INTE -- $72,737.28 1,804 BRXB0C0
0.09% ALVO ALVOTECH SA -- $71,309.61 12,989 BPNTJ34
0.09% QURE UNIQURE NV -- $68,216.04 2,283 BJFSR88
0.09% TWST TWIST BIOSCIENCE CORP -- $67,309.35 2,505 BGKG6G7
0.08% MNKD MANNKIND CORP -- $64,439.10 12,735 BF081J4
0.08% HROW HARROW INC -- $62,612.65 1,535 BHNDW86
0.08% BCRX BIOCRYST PHARMACEUTICALS INC -- $61,688.04 8,713 2100362
0.08% STOK STOKE THERAPEUTICS INC -- $60,310.25 2,275 BJQ05Z6
0.08% COLL COLLEGIUM PHARMACEUTICAL INC -- $60,141.84 1,308 BX7RSN3
0.08% PGEN PRECIGEN INC -- $59,970.25 12,365 BKM5C84
0.08% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $59,748.90 1,662 BLCD809
0.08% SNDX SYNDAX PHARMACEUTICALS INC -- $59,449.74 3,577 BN7Q7R7
0.08% SYRE SPYRE THERAPEUTICS INC -- $58,891.00 2,506 BQBBDY8
0.08% ARDX ARDELYX INC -- $58,600.00 10,000 BN89V40
0.08% INVA INNOVIVA INC -- $58,228.25 2,617 BDDXF67
0.08% ZYME ZYMEWORKS INC -- $57,782.40 3,120 BPCQZY9
0.07% TRVI TREVI THERAPEUTICS INC -- $57,463.98 5,054 BJH9ZN0
0.07% ELVN ENLIVEN THERAPEUTICS INC -- $54,225.99 2,457 BMFD115
0.07% DVAX DYNAVAX TECHNOLOGIES CORP -- $53,817.96 4,866 BRJZSK0
0.07% GMAB GENMAB A/S -SP ADR -- $52,652.40 1,740 BBC9WC7
0.07% NVCR NOVOCURE LTD -- $52,524.80 4,640 BYSS4X4
0.07% AMPH AMPHASTAR PHARMACEUTICALS IN -- $50,269.74 1,929 BNFWZS4
0.06% ORIC ORIC PHARMACEUTICALS INC -- $49,367.50 4,030 BKVDFF7
0.06% CVAC CUREVAC NV -- $49,341.60 9,345 BN4RD42
0.06% XERS XERIS BIOPHARMA HOLDINGS INC -- $48,127.54 6,703 BLR7H87
0.06% INBX INHIBRX BIOSCIENCES INC -- $47,636.26 602 BNSP8K3
0.06% NVAX NOVAVAX INC -- $46,977.80 6,740 BJDQXG4
0.06% AMLX AMYLYX PHARMACEUTICALS INC -- $46,940.31 3,699 BPCK358
0.06% WVE WAVE LIFE SCIENCES LTD -- $46,756.32 6,604 BYZG9R0
0.06% TSHA TAYSHA GENE THERAPIES INC -- $46,751.60 11,320 BNC1BX1
0.06% ABCL ABCELLERA BIOLOGICS INC -- $45,767.07 12,403 BL53SR3
0.06% URGN UROGEN PHARMA LTD -- $45,642.96 1,921 BZ7PJQ1
0.06% RLAY RELAY THERAPEUTICS INC -- $45,004.95 7,155 BN2R582
0.06% PCRX PACIRA BIOSCIENCES INC -- $44,349.70 1,865 B3X26D8
0.06% XNCR XENCOR INC -- $44,207.73 2,961 BGCYWN8
0.06% GRFS GRIFOLS SA-ADR -- $44,098.73 5,063 B8K7T65
0.06% ZLAB ZAI LAB LTD-ADR -- $43,195.50 1,986 BD9GVY0
0.06% SANA SANA BIOTECHNOLOGY INC -- $42,840.63 10,737 BMFJJ97
0.06% PHAT PHATHOM PHARMACEUTICALS INC -- $42,835.52 2,942 BJLKVS6
0.05% ORKA ORUKA THERAPEUTICS INC -- $42,028.16 1,552 BKVF0J2
0.05% NRIX NURIX THERAPEUTICS INC -- $40,627.20 3,174 BMVLGP2
0.05% KURA KURA ONCOLOGY INC -- $40,360.41 3,602 BYZD465
0.05% CSTL CASTLE BIOSCIENCES INC -- $40,206.90 1,202 BKLCWZ3
0.05% ANAB ANAPTYSBIO INC -- $39,332.66 1,163 BDRW1L7
0.05% FTRE FORTREA HOLDINGS INC -- $39,214.47 3,767 BRXYZ57
0.05% NTLA INTELLIA THERAPEUTICS INC -- $38,749.80 4,454 BYZM6C2
0.05% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $38,109.50 845 BL95N25
0.05% TNGX TANGO THERAPEUTICS INC -- $37,737.23 4,619 BP2P6L0
0.05% DAWN DAY ONE BIOPHARMACEUTICALS I -- $37,400.00 4,250 BLB0YH0
0.05% IOVA IOVANCE BIOTHERAPEUTICS INC -- $37,096.93 15,019 BF0DMK7
0.05% RAPP RAPPORT THERAPEUTICS INC -- $36,920.55 1,515 BR3T9B6
0.05% GLUE MONTE ROSA THERAPEUTICS INC -- $36,804.68 2,563 BP7KZP7
0.05% TBPH THERAVANCE BIOPHARMA INC -- $36,345.10 2,090 BMNDK09
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $35,965.64 7,957 BZ0QMB7
0.05% MNMD MIND MEDICINE MINDMED INC -- $35,866.00 3,160 BPQYY97
0.05% TYRA TYRA BIOSCIENCES INC -- $34,841.95 2,215 BMVNDH9
0.05% CRMD CORMEDIX INC -- $34,832.76 3,099 BJ0LT31
0.05% AVBP ARRIVENT BIOPHARMA INC -- $34,821.27 1,683 BMGTLY5
0.04% SPRY ARS PHARMACEUTICALS INC -- $33,669.21 4,101 BMCR7V2
0.04% EYPT EYEPOINT PHARMACEUTICALS INC -- $33,141.96 2,862 BMGS7L1
0.04% VIR VIR BIOTECHNOLOGY INC -- $32,456.95 5,765 BK4PZ38
0.04% ARVN ARVINAS INC -- $32,206.79 3,047 BDZ30Q0
0.04% RIGL RIGEL PHARMACEUTICALS INC -- $31,245.30 745 BQD3J33
0.04% SVRA SAVARA INC -- $30,852.50 7,175 BYXGN81
0.04% ERAS ERASCA INC -- $30,376.92 11,774 BNLYBF3
0.04% LENZ LENZ THERAPEUTICS INC -- $30,284.80 1,183 BQV0J03
0.04% GERN GERON CORP -- $29,656.48 26,479 2370381
0.04% ATXS ASTRIA THERAPEUTICS INC -- $29,451.51 2,343 BMYRFN8
0.04% REPL REPLIMUNE GROUP INC -- $29,136.59 3,241 BDDVW37
0.04% KROS KEROS THERAPEUTICS INC -- $29,065.84 1,684 BM7V485
0.04% MESO MESOBLAST LTD- SPON ADR -- $28,919.66 1,958 BQS7491
0.04% KALV KALVISTA PHARMACEUTICALS INC -- $28,452.18 2,089 BD06CS0
0.04% PSNL PERSONALIS INC -- $27,636.80 3,680 BJQ0608
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $27,338.22 3,338 BFYQFJ2
0.04% CRVS CORVUS PHARMACEUTICALS INC -- $27,134.38 3,094 BYP80F1
0.04% AQST AQUESTIVE THERAPEUTICS INC -- $27,052.41 5,019 BYVQJ96
0.03% PRME PRIME MEDICINE INC -- $24,459.46 7,258 BPBJFM7
0.03% ESPR ESPERION THERAPEUTICS INC -- $24,270.10 8,369 BBNBTD2
0.03% RGNX REGENXBIO INC -- $24,113.45 2,095 BZ0G875
0.03% OLMA OLEMA PHARMACEUTICALS INC -- $23,923.20 2,848 BMZ4LN0
0.03% LXRX LEXICON PHARMACEUTICALS INC -- $22,475.16 15,084 BWFZX59
0.03% OMER OMEROS CORP -- $22,232.75 2,825 B4NB858
0.03% ALMS ALUMIS INC -- $22,195.92 4,021 BPLQG36
0.03% PRTA PROTHENA CORP PLC -- $22,173.69 2,233 B91XRN2
0.03% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $21,861.84 6,006 BMCWKZ2
0.03% IRWD IRONWOOD PHARMACEUTICALS INC -- $21,163.60 6,740 B3MZ6K5
0.03% CGEM CULLINAN THERAPEUTICS INC -- $20,947.50 2,450 BM90J52
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $20,911.02 1,938 BKLXFX5
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $20,699.28 2,331 BLFBZ32
0.03% LXEO LEXEO THERAPEUTICS INC -- $20,249.60 2,240 BQ6C357
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $20,071.87 12,467 B4N8MH9
0.03% CMPS COMPASS PATHWAYS PLC -- $19,815.44 3,807 BMC3HS7
0.03% HCM HUTCHMED CHINA-ADR -- $19,438.12 1,289 BYXV9H7
0.03% EOLS EVOLUS INC -- $19,392.92 2,686 BDRJH21
0.02% GLPG GALAPAGOS NV-SPON ADR -- $18,648.84 596 B292NQ7
0.02% SIGA SIGA TECHNOLOGIES INC -- $17,832.00 2,972 2107437
0.02% NMRA NEUMORA THERAPEUTICS INC -- $17,810.65 6,721 BN4JN37
0.02% ABSI ABSCI CORP -- $17,503.74 6,207 BN94K69
0.02% DSGN DESIGN THERAPEUTICS INC -- $17,415.31 2,363 BMFK3H6
0.02% ALT ALTIMMUNE INC -- $15,278.88 3,664 BFY7DC4
0.02% TECX TECTONIC THERAPEUTIC INC -- $14,387.04 776 BPBPCG8
0.02% AURA AURA BIOSCIENCES INC -- $14,250.81 2,577 BP81R42
0.02% TRDA ENTRADA THERAPEUTICS INC -- $13,825.00 1,580 BP81RK8
0.02% ACIU AC IMMUNE SA -- $13,709.43 4,167 BZC0D70
0.02% SLDB SOLID BIOSCIENCES INC -- $13,707.92 3,233 BQHN6C7
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $13,664.00 4,480 BDFKQ07
0.02% AMRN AMARIN CORP PLC -ADR -- $13,660.24 836 BN72KB0
0.02% LYEL LYELL IMMUNOPHARMA INC -- $13,527.07 799 BTNMG41
0.02% NGNE NEUROGENE INC -- $13,525.38 594 BS2F741
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $13,311.67 1,949 BL5B6Z1
0.02% AVXL ANAVEX LIFE SCIENCES CORP -- $12,987.14 3,563 BYTYP72
0.02% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $12,441.60 1,920 BKDQKM6
0.02% ANNX ANNEXON INC -- $12,360.31 4,561 BMVV9R5
0.02% KYTX KYVERNA THERAPEUTICS INC -- $12,349.60 1,795 BSMLR16
0.02% LRMR LARIMAR THERAPEUTICS INC -- $12,002.38 3,551 BMXNGZ6
0.01% AUTL AUTOLUS THERAPEUTICS PLC -- $11,403.88 8,324 BFMLGR4
0.01% ALLO ALLOGENE THERAPEUTICS INC -- $11,327.07 9,209 BFZNYB7
0.01% PYXS PYXIS ONCOLOGY INC -- $11,218.28 2,573 BLBR8D5
0.01% FHTX FOGHORN THERAPEUTICS INC -- $11,007.43 2,347 BMF7DT9
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $10,709.28 888 B9L5200
0.01% VNDA VANDA PHARMACEUTICALS INC -- $10,661.85 2,451 B12W3P6
0.01% TKNO ALPHA TEKNOVA INC -- $9,883.45 2,221 BP7L561
0.01% AVIR ATEA PHARMACEUTICALS INC -- $9,753.20 3,295 BLN9Z50
0.01% EDIT EDITAS MEDICINE INC -- $9,705.80 3,733 BZ8FPH3
0.01% VYGR VOYAGER THERAPEUTICS INC -- $9,042.93 2,301 BY7RB53
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $8,186.02 1,126 BKC9SX3
0.01% HUMA HUMACYTE INC -- $8,086.02 6,574 BMYTJP4
0.01% RNAC CARTESIAN THERAPEUTICS INC -- $8,064.26 1,081 BQB9HM8
0.01% OABI OMNIAB INC -- $7,941.96 5,091 BN13S71
0.01% CCCC C4 THERAPEUTICS INC -- $7,298.85 2,955 BKX9NQ0
0.01% MXCT MAXCYTE INC -- $6,991.50 4,425 BKMQF66
0.01% PEPG PEPGEN INC -- $6,460.62 1,363 BMTX3D7
0.01% CDXS CODEXIS INC -- $6,162.17 3,746 B5LL2C2
0.01% MRSN MERSANA THERAPEUTICS INC -- $5,779.44 207 BVPKH99
0.01% NKTX NKARTA INC -- $5,516.50 2,950 BK80YJ8
0.01% CLYM CLIMB BIO INC -- $5,346.60 2,814 BMW5LX6
0.01% ALEC ALECTOR INC -- $5,210.48 4,202 BJ4LDC4
0.01% FATE FATE THERAPEUTICS INC -- $4,613.70 4,786 BCZS820
0.01% PLRX PLIANT THERAPEUTICS INC -- $4,282.32 2,549 BMDWW66
0.01% MGNX MACROGENICS INC -- $3,936.00 2,624 BFDV8K0
-- TVGN TEVOGEN BIO HOLDINGS INC -- $3,405.62 8,165 BPG5P75
-- ARTV ARTIVA BIOTHERAPEUTICS INC -- $3,298.75 1,015 BMF1LJ7
-- STRO SUTRO BIOPHARMA INC -- $3,183.99 3,519 BF12XC2
-- BMEA BIOMEA FUSION INC -- $3,162.88 2,471 BNKF6N0
-- ACRV ACRIVON THERAPEUTICS INC -- $2,925.44 1,306 BP2TPK4
-- TCRX TSCAN THERAPEUTICS INC -- $2,393.60 2,176 BNLYBJ7
-- OKUR ONKURE THERAPEUTICS INC-A -- $1,671.42 534 BT7KGT6
-- APLT APPLIED THERAPEUTICS INC -- $1,301.07 5,960 BJL38Z1
-- QTTB Q32 BIO INC -- $1,090.80 505 BS2FKQ4
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
35.22% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 27,080,848 -- 4,905 --
35.17% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 27,047,722 -- 4,899 --
22.08% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 16,977,290 -- 3,075 --
17.83% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 13,714,338 -- 2,484 --
16.51% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 12,692,940 -- 2,299 --
8.29% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 6,376,836 -- 1,155 --
-- -- TREASURY BILL -- $4,998,409.15 5,000,000 BMGHP58
-- -- NET OTHER ASSETS (LIABILITIES) -- $21,860,398.12 21,860,398 --

Index

as of 9/30/2025

  • Total Number of Companies251
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$6.56 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.